Johnson & Johnson is ending sales of its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it causes cancer.
The world’s biggest maker of health care products said their baby powder will still be sold outside the U.S. and Canada.
“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said.
J&J has faced thousand of lawsuits alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma.
